← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (676)Review article (146)Early study (phase 1 or 2) (12)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. (2017/12/28) ♡
• Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1. (2017/12/28) ♡
• Quality of life in Brazilian patients with treated or untreated chronic hepatitis C. (2017/12/21) ♡
• Rapid and large-scale implementation of HCV treatment advances in France, 2007-2015. (2017/12/20) ♡
• [Hepatitis C-related hepatocellular carcinoma and the treatment with direct-acting antiviral agents]. (2017/12/20) ♡
• Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience. (2017/12/20) ♡
• The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. (2017/12/19) ♡
• Association of interferon gamma gene polymorphism and susceptibility to hepatitis C virus infection in Egyptian patients: A multicenter, family-based study. (2017/12/19) ♡
• Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional study. (2017/12/18) ♡
• Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort (2017/12/18) ♡
• Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1. (2017/12/01) ♡
• Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population. (2017/12/01) ♡
• New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatocellular Carcinoma Occurrence and Recurrence after Antiviral Treatment in HCV-Related Cirrhosis. Are Outcomes Different after Direct Antiviral Agents? A Review. (2017/12/01) ♡
• Estudio de impacto presupuestal de Daclatasvir asociado a Asunaprevir desde la perspectiva del sistema de salud público chileno. (2017/12/01) ♡
• Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C. (2017/12/01) ♡
• Comparison of metformin and pioglitazone in achieving sustained virological response in chronic hepatitis C patients with insulin resistance: A quasi-experimental study. (2017/12/01) ♡
• Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C. (2017/12/01) ♡
• Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus-related liver disease. (2017/12/01) ♡
• Brief report: Prevalence of hepatitis B and C virus infections in U.S. Air Force basic military trainees who donated blood, 2013-2016. (2017/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection. (2017/12/01) ♡
• [First experience with elbasvir/grazoprevir fixed-dose combination in real-life practice in the Czech Republic]. (2017/12/01) ♡
• Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older. (2017/12/01) ♡
• High prevalence of insulin resistance among Brazilian chronic hepatitis C patients. (2017/12/01) ♡
• A SPECIAL MEETING REVIEW EDITION: Highlights in Hepatitis C Virus From the 2017 AASLD Liver Meeting: A Review of Selected Presentations From the 2017 AASLD Liver Meeting • October 20-24, 2017 • Washington, DCSpecial Reporting on:• Efficacy, Safety, and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis• Hepatitis C Virus Reinfection and Injecting Risk Behavior Following Elbasvir/Grazoprevi (2017/12/01) ♡
• Significance of growth differentiation factor 15 in chronic HCV patients. (2017/12/01) ♡
• Asunaprevir and daclatasvir in haemodialysis patients with chronic hepatitis C virus genotype 1b infection. (2017/11/28) ♡
• Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors. (2017/11/22) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Vitamin D supplementation for chronic liver diseases in adults. (2017/11/03) ♡
• Pentagalloyl glucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry. (2017/11/01) ♡
• Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S. (2017/11/01) ♡
• Distribution of polymorphisms rs12979860, rs8099917 and rs12980275 IL28B in patients with chronic hepatitis C. (2017/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the Amazon. (2017/11/01) ♡
• Epidemiology of Chronic Hepatitis C Infections at a Tertiary Care Center in Oman. (2017/11/01) ♡
• Prevalence of chronic viral hepatitis infections in Karaj, Iran. (2017/10/30) ♡
• Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay. (2017/10/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis. (2017/10/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. (2017/10/01) ♡
• Treatment Related Hematologic Changes in a Population of Iranian Patients with Chronic Hepatitis C Infection from 2009 to 2014. (2017/10/01) ♡
• Analysis of TLR7, SOCS1 and ISG15 immune genes expression in the peripheral blood of responder and non-responder patients with chronic Hepatitis C. (2017/10/01) ♡
• The relationship between expression of Toll-like receptor 4 in chronic hepatitis C patients and different stages of liver fibrosis. (2017/10/01) ♡
• Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders. (2017/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Porphyria cutanea tarda as extrahepatic manifestation of chronic hepatitis C: a case report]. (2017/10/01) ♡
• [Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients]. (2017/10/01) ♡
• Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. (2017/09/28) ♡
• Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway. (2017/09/16) ♡
• Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme. (2017/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The impact of nutrition on the quality of life of patients with hepatitis C. (2017/09/01) ♡
• Effect of Vitamin D Serum Levels and GC Gene Polymorphisms in Liver Fibrosis Due to Chronic Hepatitis C. (2017/09/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis. (2017/08/24) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.